Immunohistochemical analysis of Marinesco bodies, using antibodies against proteins implicated in the ubiquitin-proteasome system, autophagy and aggresome formation

Neuropathology

Volumn 32, Issue 3, 2012, Pages 261-266

  Odagiri, Saori ^a   Tanji, Kunikazu ^a   Mori, Fumiaki ^a   Kakita, Akiyoshi ^b   Takahashi, Hitoshi ^b   Kamitani, Tetsu ^c   Wakabayashi, Koichi ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Aggresome; Autophagy; Immunohistochemistry; Marinesco body; SUMO; Ubiquitin proteasome system

Indexed keywords

CELL PROTEIN; E3 ISOLATED BY DIFFERENTIAL DISPLAY 1 PROTEIN; GAMMA AMINOBUTYRIC ACID TYPE A RECEPTOR ASSOCIATED PROTEIN; GOLGI ASSOCIATED ADENOSINE TRIPHOSPHATASE ENHANCER OF 16 KDA; HISTONE DEACETYLASE 6; MICROTUBULE-ASSOCIATED PROTEIN 1 LIGHT CHAIN 3; NEDD8 PROTEIN; NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWN REGULATED PROTEIN 8 ULTIMATE BUSTER 1 PROTEIN; PROTEASOME; PROTEIN P62; SUMO 1 PROTEIN; SUMO 2 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; AGED; AGGRESOME; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MARINESCO BODY; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; AUTOPHAGY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUBSTANTIA NIGRA; UBIQUITIN;

EID: 84861531546     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01267.x     Document Type: Article

References (45)

1. Schochet SS, Jr. Neuronal inclusions. In: Bourne GH, ed. The Structure and Function of Nervous System. New York: Academic Press, 1972; 129-177.
2. Leestma JE, Andrews JM. The fine structure of the Marinesco body. Arch Pathol 1969; 88: 431-436.
3. Ikeda K. A study of the Marinesco body in monkey (Macaca fuscata). A comparative study to the Marinesco body in man (in Japanese with English abstract). Seishin Shinkeigaku Zasshi 1974; 76: 778-792.
4. Okamoto K, Hirai S. Fine structures of Marinesco body and nuclear body in the substantia nigra (in Japanese with English abstract). Clin Neurol (Tokyo) 1981; 21: 781-789.
5. Yuen P, Baxter DW. The morphology of Marinesco bodies (paranucleolar corpuscles) in the melanin-pigmented nuclei of the brain-stem. J Neurol Neurosurg Psychiatry 1963; 26: 178-183.
6. Hirai S, Morimatsu M, Muramatsu A, Eto F, Yoshikawa M. Aging of the substantia nigra with special reference to the Marinesco body (in Japanese with English abstract). Nihon Ronen Igakukai Zasshi 1977; 14: 6-13.
7. Shiraki H, Yamamoto T. Histochemical aspects of hepatocerebral diseases. With especial reference to inclusion bodies. Shinkei Shinpo 1960; 5: 73-101.
8. Kumada S, Uchihara T, Hayashi M etal. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies. J Neuropathol Exp Neurol 2002; 61: 984-991.
9. Ono S, Inoue K, Mannen T etal. Intracytoplasmic inclusion bodies of the thalamus and the substantia nigra, and Marinesco bodies in myotonic dystrophy: a quantitative morphological study. Acta Neuropathol 1989; 77: 350-356.
10. Beach TG, Walker DG, Sue LI, Newell A, Adler CC, Joyce JN. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers. J Neuropathol Exp Neurol 2004; 63: 329-337.
11. Quan L, Zhu BL, Ishida K etal. Intranuclear ubiquitin immunoreactivity of the pigmented neurons of the substantia nigra in fatal acute mechanical asphyxiation and drowning. Int J Legal Med 2001; 115: 6-11.
12. Bancher C, Lassmann H, Budka H etal. An antigenic profile of Lewy bodies: immunocytochemical indication for protein phosphorylation and ubiquitination. J Neuropathol Exp Neurol 1989; 48: 81-93.
13. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen SH. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 1990; 63: 87-99.
14. Kuusisto E, Kauppinen T, Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol Appl Neurobiol 2008; 34: 169-180.
15. Takahashi-Fujigasaki J, Fujigasaki H. Histone deacetylase (HDAC) 4 involvement in both Lewy and Marinesco bodies. Neuropathol Appl Neurobiol 2006; 32: 562-566.
16. Lieberman AP. SUMO, a ubiquitin-like modifier implicated in neurodegeneration. Exp Neurol 2004; 185: 204-207.
17. Martin S, Wikinson KA, Nishimune A, Henley JM. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 2007; 8: 948-959.
18. Meulmeester E, Melchior F. Cell biology: SUMO. Nature 2008; 452: 709-711.
19. Mori F, Tanji K, Kon T etal. FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease. Neuropathol Appl Neurobiol 2011; doi: 10.1111/j.1365-2990.2011.01217.x.
20. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol 2004; 24: 8055-8068.
21. Bjørkøy G, Lamark T, Brech A etal. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171: 603-614.
22. Kozlov G, Nguyen L, Lin T, De Crescenzo G, Park M, Gehring K. Structural basis of ubiquitin recognition by the ubiquitin-associated (UBA) domain of the ubiquitin ligase EDD. J Biol Chem 2007; 282: 35787-35795.
23. Kamitani T, Kito K, Fukuda-Kamitani T, Yeh ET. Targeting of NEDD8 and its conjugates for proteasomal degeradation by NUB1. J Biol Chem 2001; 276: 46655-46660.
24. Mori F, Nishie M, Piao YS etal. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Neuropathol Appl Neurobiol 2005; 31: 53-61.
25. Tanji K, Tanaka T, Mori F etal. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1. Am J Pathol 2006; 169: 553-565.
26. Tanji K, Mori F, Kakita A etal. Immunohistochemical localization of NUB1, a synphilin-1-binding protein, in neurodegenerative disorders. Acta Neuropathol 2007; 114: 365-371.
27. Wakabayashi K, Engelender S, Tanaka Y etal. Immunocytochemical localization of synphilin-1, an α-synuclein-associated protein, in neurodegenerative disorders. Acta Neuropathol 2002; 103: 209-214.
28. Wakabayashi K, Hayashi S, Kakita A etal. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy. Acta Neuropathol 1998; 96: 445-452.
29. Pountney DL, Chegini F, Shen X, Blumbergs PC, Gai WP. SUMO-1 marks subdomains within glial cytoplasmic inclusions of multiple system atrophy. Neurosci Lett 2005; 381: 74-79.
30. Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death. Neuroreport 2002; 13: 2359-2364.
31. Dorval V, Fraser PE. SUMO on the road to neurodegeneration. Biochim Biophys Acta 2007; 1773: 694-706.
32. Pountney DL, Huang Y, Burns RJ etal. SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease. Exp Neurol 2003; 184: 436-446.
33. Schimmel J, Larsen KM, Matic I etal. The ubiquitin-pototeasome system is a key component of the SUMO-2/3 cycle. Mol Cell Proteomics 2008; 7: 2107-2122.
34. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A, Yao TP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 2003; 115: 727-738.
35. Miki Y, Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions. Neuropathology 2011; doi: 10.1111/j.1440-1789.2011.01200.x. [Epub ahead of print].
36. Mori F, Miki Y, Tanji K etal. Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology 2011; 31: 188-193.
37. Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 2010; 29: 1792-1802.
38. Drake KR, Kang M, Kenworthy AK. Nucleocytoplasmic distribution and dynamics of the autophagosome marker EGFP-LC3. PLoS ONE 2010; 5: e9806.
39. Fujigasaki H, Uchihara T, Takahashi J etal. Preferential recruitment of ataxin-3 independent of expanded polyglutamine: an immunohistochemical study on Marinesco bodies. J Neurol Neurosurg Psychiatry 2001; 71: 518-520.
40. Kettner M, Willwohl D, Hubbard GB etal. Intranuclear aggregation of nonexpanded ataxin-3 in Marinesco bodies of the nonhuman primate substantia nigra. Exp Neurol 2002; 176: 117-121.
41. Mizuno Y, Hori S, Kakizuka A, Okamoto K. Vacuole-creating protein in neurodegenerative diseases in humans. Neurosci Lett 2003; 343: 77-80.
42. Fujigasaki H, Uchihara T, Koyano S etal. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp Neurol 2000; 165: 248-256.
43. Yamada M, Sato T, Shimohata T etal. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases. Am J Pathol 2001; 159: 1785-1795.
44. Hirabayashi M, Inoue K, Tanaka K etal. VCP/p97 is abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ 2001; 8: 977-984.
45. Takahashi J, Fujigasaki H, Iwabuchi K etal. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases. Neurobiol Dis 2003; 13: 230-237.